» Articles » PMID: 25238934

Subjective and Objective Cognitive Decline at the Pre-dementia Stage of Alzheimer's Disease

Overview
Specialties Neurology
Psychiatry
Date 2014 Sep 21
PMID 25238934
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Research on Alzheimer's disease (AD) dementia prediction has moved from the mild cognitive impairment stage to the preclinical stage of AD. This has also extended the focus from the early clinical sign of cognitive impairment measured with neuropsychological tests to the purely subjective report of cognitive decline (SCD) in unimpaired elderly individuals. Epidemiological studies have shown that both objective impairment and SCD are independently predictive of AD dementia. Both are also associated with an increased likelihood of biomarker or neuroimaging evidence of AD. However, the relationship of objective and subjective cognitive performance along the axis of AD development and their role at different stages in prediction of AD dementia is not well explored. Refined knowledge about strengths and weaknesses of both aspects at different pre-dementia disease stages will be beneficial for dementia prediction. Both concepts and their interaction are introduced in this article.

Citing Articles

Association of Subjective Cognitive Concerns With Performance on Mobile App-Based Cognitive Assessment in Cognitively Normal Older Adults: Observational Study.

Nester C, De Vito A, Prieto S, Kunicki Z, Strenger J, Harrington K JMIR Aging. 2025; 8:e64033.

PMID: 39903213 PMC: 11812482. DOI: 10.2196/64033.


Proof-of-concept for integrating multimodal digital health assessments into lifestyle interventions for older adults with dementia risk factors.

Schroeder M, Frumkin M, Mace R J Behav Med. 2025; .

PMID: 39833389 DOI: 10.1007/s10865-024-00546-7.


Research on the application of functional near-infrared spectroscopy in differentiating subjective cognitive decline and mild cognitive impairment.

Wang Z, Niu C, Duan Y, Yang H, Mi J, Liu C Front Aging Neurosci. 2025; 16():1469620.

PMID: 39777048 PMC: 11703808. DOI: 10.3389/fnagi.2024.1469620.


A Mindfulness-Based Lifestyle Intervention for Dementia Risk Reduction: Protocol for the My Healthy Brain Feasibility Randomized Controlled Trial.

Mace R, Law M, Cohen J, Ritchie C, Okereke O, Hoeppner B JMIR Res Protoc. 2024; 13:e64149.

PMID: 39571150 PMC: 11621724. DOI: 10.2196/64149.


Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort.

Castilla-Marti L, Garcia-Sanchez A, Martinez J, Rosende-Roca M, Vargas L, Tartari J Alzheimers Res Ther. 2024; 16(1):249.

PMID: 39550564 PMC: 11568571. DOI: 10.1186/s13195-024-01616-3.